Senescence
Conditions
Interventions
Test group:Take PQQ capsules orally, 1 capsule per day for 56 consecutive days
placebo group:Take placebo capsules orally, 1 capsule per day for 56 consecutive days
Sponsors
The First People's Hospital of Kunshan
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: [1] Healthy adults aged 35-70 years, both men and women; [2] No history of long-term medication; [3] Signed informed consent;
Exclusion criteria
Exclusion criteria: [1] Pregnant and lactating women and those who plan to become pregnant during the trial period; [2] Patients with severe heart, liver, or kidney dysfunction, malignant tumors, and mental illness; [3] Patients with a known or suspected history of allergy to PQQ and its excipients; [4] Patients who have participated in other drug clinical trials within 1 month before screening; [5] Patients with a history of alcoholism or drug abuse within 1 year before screening; [6] Patients who are considered by the investigator to have poor compliance or who are considered by the investigator to have any other conditions that make them unsuitable for participation in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sirt 1; | — |
Secondary
| Measure | Time frame |
|---|---|
| NAD+;MDA;SOD;Fatigue self-rating scale; | — |
Countries
China
Contacts
Public ContactGuo Zhengli
Kunshan First People's Hospital
Outcome results
None listed